ORMP
Oramed Pharmaceuticals, Inc
Halal Rating :
Last Price
$2.28
Last updated:
Market Cap
-
7D Change
-3.6%
1 Year Change
3.17%
Company Overview
Industries
Exchange
Next Earnings Date
Oramed Pharmaceuticals is a biotechnology company focused on developing oral delivery solutions for drugs and vaccines currently delivered via injection. Their primary product candidate is ORMD-0801, an oral insulin capsule for the treatment of diabetes. The company was founded in 2006 and is headquartered in New York, with research and development activities in Israel.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Oramed Pharmaceuticals, Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.